NET PROFIT (x1000 NOK)
EMPLOYEES
Acadia Pharmaceuticals A/S
Closing information (x1000 NOK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-28
|
-81
|
-99 |
| Total assets |
8
|
16
|
4 |
| Current assets |
8
|
16
|
4 |
| Current liabilities |
797
|
817
|
676 |
| Equity capital |
-789
|
-801
|
-673 |
| - share capital |
806
|
849
|
794 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
-9862.5%
|
-5006.2%
|
-16825.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
1.0%
|
2.0%
|
0.6% |
| Return on equity (ROE) |
3.5%
|
10.1%
|
14.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.